| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,060,260 ) |
| | 2025 | 2025 | LENA BIOSCIENCES, INC. | 6065 ROSWELL RD STE 420 | ATLANTA | GA | 30328-4014 | FULTON | USA | R44ES036492 | An integrated MPS platform with "virtual humans" for chemical toxicity testing | 000 | 2 | NIH | 8/7/2025 | $1,060,260 |
|
| Issue Date FY: 2024 ( Subtotal = $1,823,454 ) |
| | 2024 | 2024 | LENA BIOSCIENCES, INC. | 311 FERST DR NW | ATLANTA | GA | 30332-0390 | FULTON | USA | R44ES032355 | Perfused organ panel as an animal surrogate for chemical toxicity testing | 000 | 3 | NIH | 5/6/2024 | $922,650 |
| | 2024 | 2024 | LENA BIOSCIENCES, INC. | 311 FERST DR NW | ATLANTA | GA | 30332-0390 | FULTON | USA | R44ES036492 | An integrated MPS platform with "virtual humans" for chemical toxicity testing | 000 | 1 | NIH | 8/22/2024 | $900,804 |
| | 2024 | 2023 | LENA BIOSCIENCES, INC. | 311 FERST DR NW | ATLANTA | GA | 30332-0390 | FULTON | USA | R43TR004290 | A microphysiological system with a synthetic hemoglobin, Blood Substitute, for mechanistic assessment of drug-induced liver injury | 000 | 2 | NIH | 4/16/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $960,049 ) |
| | 2023 | 2023 | LENA BIOSCIENCES, INC. | 311 FERST DR NW | ATLANTA | GA | 30332-0390 | FULTON | USA | R43TR004290 | A microphysiological system with a synthetic hemoglobin, Blood Substitute, for mechanistic assessment of drug-induced liver injury | 000 | 2 | NIH | 4/22/2023 | $78,873 |
| | 2023 | 2023 | LENA BIOSCIENCES, INC. | 311 FERST DR NW | ATLANTA | GA | 30332-0390 | FULTON | USA | R44ES032355 | Perfused organ panel as an animal surrogate for chemical toxicity testing | 000 | 2 | NIH | 5/5/2023 | $881,176 |
|
| Issue Date FY: 2022 ( Subtotal = $221,075 ) |
| | 2022 | 2022 | LENA BIOSCIENCES, INC. | 311 FERST DR | ATLANTA | GA | 30332-0001 | FULTON | USA | R43TR004290 | A microphysiological system with a synthetic hemoglobin, Blood Substitute, for mechanistic assessment of drug-induced liver injury | 000 | 1 | NIH | 5/20/2022 | $221,075 |
| | 2022 | 2020 | LENA BIOSCIENCES, INC. | 311 FERST DR NW | ATLANTA | GA | 30332-0390 | FULTON | USA | R43ES032355 | Perfused organ panel as an animal surrogate for chemical toxicity testing | 000 | 1 | NIH | 3/24/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | LENA BIOSCIENCES, INC. | 311 FERST DR | ATLANTA | GA | 30332-0001 | FULTON | USA | R44TR001286 | Tools for drug efficacy studies in perfused tissue models | 000 | 3 | NIH | 8/17/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $252,124 ) |
| | 2020 | 2020 | LENA BIOSCIENCES, INC. | 311 FERST DRIVE | ATLANTA | GA | 30332-0001 | FULTON | USA | R43ES032355 | Perfused organ panel as an animal surrogate for chemical toxicity testing | 000 | 1 | NIH | 7/30/2020 | $252,124 |
|
| Issue Date FY: 2019 ( Subtotal = $721,610 ) |
| | 2019 | 2019 | LENA BIOSCIENCES, INC. | 311 FERST DRIVE | ATLANTA | GA | 30332-0001 | FULTON | USA | R44TR001286 | Tools for drug efficacy studies in perfused tissue models | 000 | 3 | NIH | 7/10/2019 | $721,610 |
|
| Issue Date FY: 2018 ( Subtotal = $724,224 ) |
| | 2018 | 2018 | LENA BIOSCIENCES, INC. | 311 FERST DRIVE | ATLANTA | GA | 30332-0001 | FULTON | USA | R44TR001286 | Tools for drug efficacy studies in perfused tissue models | 000 | 2 | NIH | 6/22/2018 | $724,224 |
| | 2018 | 2016 | LENA BIOSCIENCES, INC. | 311 FERST DRIVE | ATLANTA | GA | 30332-0001 | FULTON | USA | R43TR001286 | Tools for drug efficacy studies in perfused tissue models | 000 | 1 | NIH | 5/21/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $325,000 ) |
| | 2016 | 2016 | MICROPERFUSIONS, INC. | 3779 Chtthochee Summit Dr | Atlanta | GA | 30339-3246 | COBB | USA | R43TR001286 | Tools for drug efficacy studies in perfused tissue models | 000 | 1 | NIH | 4/26/2016 | $325,000 |
|
| Issue Date FY: 2010 ( Subtotal = $244,894 ) |
| | 2010 | 2010 | MICROPERFUSIONS INC | 3779 CHATTAHOOCHEE SUMMIT DR | ATLANTA | GA | 30339 | COBB | USA | R43NS065543 | DIAGNOSTIC MICROPERFUSION PLATFOM FOR FUNCTIONAL SCREENING OF THICK PREPARATIONS | 002 | 2 | NIH | 8/24/2010 | $0 |
| | 2010 | 2010 | MICROPERFUSIONS, INC. | 3779 Chtthochee Summit Dr | Atlanta | GA | 30339-3246 | COBB | USA | R43NS065543 | DIAGNOSTIC MICROPERFUSION PLATFOM FOR FUNCTIONAL SCREENING OF THICK PREPARATIONS | 001 | 2 | NIH | 7/21/2010 | $244,894 |
| | 2010 | 2009 | MICROPERFUSIONS INC | 3779 CHATTAHOOCHEE SUMMIT DR | ATLANTA | GA | 30339 | COBB | USA | R43NS065543 | DIAGNOSTIC MICROPERFUSION PLATFOM FOR FUNCTIONAL SCREENING OF THICK PREPARATIONS | 000 | 1 | NIH | 1/11/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $194,959 ) |
| | 2009 | 2009 | MICROPERFUSIONS, INC. | 3779 Chtthochee Summit Dr | Atlanta | GA | 30339-3246 | COBB | USA | R43NS065543 | DIAGNOSTIC MICROPERFUSION PLATFOM FOR FUNCTIONAL SCREENING OF THICK PREPARATIONS | 000 | 1 | NIH | 9/14/2009 | $194,959 |
|
|
